Bioengineered Protein Drugs Market- Global Future Growth, Regional Trend, Industry Demand by Forecast to 2025
Verfasser: ashwani_kailiya on Friday, 10 April 2020The global market for bioengineered protein drugs is currently highly competitive owing to the large and widespread presence of major players. Some of the top names in the global bioengineered protein drugs market include ProBioGen AG, Abbott Laboratories, Amgen, Inc., Johnson & Johnson, Bayer AG, Novartis AG, GlaxoSmithKline plc, and Biocon Ltd., among others.
Major players are pushing to bolster their product portfolios, and market penetration, which includes activities such as collaborations, acquisitions and, mergers, in addition to increasing investments into research and development activities, with the aim of developing new product offerings.
Request for Sample Report with Statistical Info @ https://www.factmr.com/connectus/sample?flag=S&rep_id=4440
The global bioengineered protein drugs market is expected to display an impressive CAGR of ~ 8.4 per cent, through the end of the forecast period in 2025. This growth rate can be primarily attributed to the high adoption rate for vaccines and will account for a value of more than USD 336 billion by the end of this period.
Prohibitive Production Costs Restrict Growth